experimental class iii antiarrhythmic drug blocks potassium channels synthesized toxin methanesulfonanilide class iii antiarrhythmic acts specific class voltagegated potassium channels mainly found heart herg channels herg channels mediate ikr current repolarizes myocardial herg channel encoded etheragogo related gene blocks hergtype potassium channels binding open structural target within hergchannel unclear methanesulfonanilide class iii antiarrhythmic drugs known bind domain cterminal reducing ikr myocardial cells prolongs cardiac action potential thus prolongs noncardiac cells blocking ikr different effect increases frequency action prolong qtinterval cause lethal solely used research purposes far one clinical trial conducted test effect prolongation